Workflow
白酒
icon
Search documents
A股开盘速递 | A股走势分化!沪指失守3800点、创指涨超1% 银行板块下挫
智通财经网· 2025-09-04 01:56
9月4日,A股早盘走势分化,沪指失守3800点,截至9:41,沪指跌0.45%,深成指涨0.77%,创业板指涨1.47%。 盘面上,新能源赛道股反弹,储能概念延续强势,固态电池放领涨,通润装备2连板;光伏概念震荡走强,安彩高科涨停;折叠屏概念股拉升,宜安科技涨 超10%。下跌方面,银行、保险等大金融板块继续走低,军工、半导体、白酒等板块跌幅居前。 展望后市,东方证券认为,市场短期进入高位震荡,波动幅度有所扩大,但调整更多体现为结构化控制,高低切换与行业轮动特征明显,预计回落幅度有 限。 热门板块 1、储能概念延续强势 机构观点 1、广发证券:建议继续坚守科技产业主线 广发证券认为,对于已经持有本轮牛市科技主线的投资者,在当前估值分化程度并不算高的位置上,去参与"高低切换"的必要性不强,建议继续坚守科技产 业主线:一方面,海外算力链、创新药仍在牛市产业主线的进程中;另一方面,国产算力、国内AI基建、AI端侧应用的产业预期也在修复当中,前期重点 推荐的科创芯片、虽迟但到。 2、东吴证券:牛市二阶段,聚焦AI应用的赔率交易 东吴证券认为,在目前量能充沛的市场环境下,主线又集中于以AI为核心的科技,若上游硬件端出现筹 ...
贵州茅台重回“A股之王”,1935价格倒挂
Xin Lang Cai Jing· 2025-09-04 01:25
智通财经记者 | 武冰聪 智通财经编辑 | 任雪松 贵州茅台重新成为了A股第一高价股。 2025年8月29日,国产芯片企业寒武纪的股价超过了贵州茅台,这一消息引发多方关注,登上热搜。 9月1日,寒武纪股价收跌2.95%,报1448.39元/股,贵州 茅台收跌0.26%,报1476.1元/股。贵州茅台股价再次超过寒武纪,重新成为A股市场第一高价股。 在随后的两天里,贵州茅台在早盘交易中展现出了强劲的势头,突破了1500元/股大关,创下了自今年5月以来的新高。 制图:智通财经 武冰聪 贵州茅台股价被超越,需要结合整个白酒板块的表现来看。 截至8月29日,全部A股上市公司半年报披露完毕。贵州茅台完成了此前制定的业绩增长9%目标。与2024年相比,茅台出现了增速放缓,但仍维持住增长势 头。 然而,智通财经统计了20家A股白酒上市公司及港股珍酒李渡共21家公司的数据,今年上半年有15家企业业绩下滑,仅有6家保持了营收与净利润增长,"双 增长"企业包括贵州茅台、五粮液、山西汾酒,它们也分别是营收规模的前三名,属于全国性名酒。 | | | 2025上半年白酒股营收与净利润增长情况 | | | | --- | --- | - ...
坚定推进战略转型创新,泸州老窖尽显发展韧性
Sou Hu Cai Jing· 2025-09-04 00:55
2025年,白酒行业进入新一轮调整周期,行业整体呈现出"量减质升"的发展态势,正加快从"存量竞争"向"价值创造"转型。2025年上半年,泸州老窖实现 营业收入164.54亿元,实现归属于上市公司股东的净利润76.63亿元。 上半年,面对新的市场环境,泸州老窖锚定"低度化、年轻化、场景化、数智化"四个战略方向,在市场拓展、管理创新、技术升级、数智应用和消费场景 打造等方面推动转型创新,以战略定力精准把握消费迭代与产业变革的时代脉搏,以主动转型构筑差异化竞争优势,进一步夯实发展韧性。 低度酒优势继续扩大 近年来,酒类产业进入消费结构转型和分化期、存量竞争的深度调整期。一个显而易见的变化是,年轻人开始成为白酒市场的主要消费群体。 业内人士表示,年轻人不是不饮酒,而是饮酒需求发生了变化。目前85后、90后,以及年轻女性成为最具潜力的酒类消费人群。相比之下,年轻消费群体 更倾向于个性化、低度化、利口化、悦己化的酒类消费,更青睐小型聚会、下班小酌等"轻社交"场景,更喜好"轻便化""高颜值"的产品设计,更推崇轻松 随性的饮酒文化。 泸州老窖在半年报中表示,下半年将持续推动产品创新,面对当前低度化、健康化、利口化、多元化等产 ...
方正证券:白酒作为优质顺周期资产 估值中枢仍存在修复空间
Xin Lang Cai Jing· 2025-09-04 00:46
方正证券研报称,白酒板块自Q2起降速,受宏观环境冲击与终端需求疲软,酒企短期业绩承压,基本 面处磨底阶段,品牌间分化加剧。分价格整体表现看,高端白酒>次高端白酒>区域酒企(次高端白酒 此前调整时间较长,地产龙头主动维护核心市场及产品基础)。高端白酒持续通过品牌高势能及渠道掌 控手段维持相对韧性。茅台等龙头通过控货挺价、优化渠道等动作,稳固高端市场基本盘,抗风险能力 显著。当前时点展望来看,多重政策催化下底部已形成,当期板块PE-TTM为19.7X,近五年分位数 14.3%,虽有所回暖但仍处历史低位。在整体经济预期好转下,白酒作为优质顺周期资产,估值中枢仍 存在修复空间,后续关注中秋&国庆对终端需求的改善,中长期跟踪政策端改善传导至需求端恢复的节 奏。 ...
清香型崛起,白酒行业深度调整中孕育新机遇
Zhong Jin Zai Xian· 2025-09-04 00:33
山西汾酒全国化战略与产品结构优化的双轮驱动,正成为低迷市场中一道亮丽的风景线。 2025年上半年,中国白酒行业步入"政策调整、消费结构转型、存量竞争"三期叠加的深度调整期。多数 酒企业绩承压,但以山西汾酒为代表的清香型白酒却逆势上扬,展现出强劲的发展韧性。山西汾酒2025 年半年报显示,公司实现营业收入239.64亿元,净利润85.05亿元,两大核心指标均保持稳健增长。在行 业整体面临挑战的背景下,汾酒凭借全国化战略推进和产品结构优化,为投资者带来了难得的信心与曙 光。 01 行业寒冬中的一抹亮色 2025年白酒中报数据呈现出一幅冰火两重天的景象。在已公布业绩的17家酒企中,仅5家实现营收正增 长,12家出现负增长,有的企业营收甚至下滑43%。行业规模以上企业数量同比减少超百家,产业产量 同比下降5.8%。终端销量冷清,中高档酒销售疲软成为常态。 在这场行业寒冬中,山西汾酒却表现稳健。公司2025年上半年总营收同比增长5.4%,归母净利润达85.1 亿元。汾酒的业绩增长背后是其全国化战略的成效显现。上半年,汾酒在山西省外市场收入达151.43亿 元,同比增长6.15%,占比已达到63.2%。 02 清香型白酒 ...
老白干酒(600559):降费增效延续 经营韧性凸显
Xin Lang Cai Jing· 2025-09-04 00:29
Core Viewpoint - The company reported its 2025 semi-annual results, showing stable revenue growth and improved profitability despite a weak macroeconomic environment [1][4]. Financial Performance - In 25H1, the company achieved revenue of 2.48 billion yuan, a year-on-year increase of 0.5%, and a net profit attributable to shareholders of 320 million yuan, up 5.4% year-on-year [1]. - For Q2 2025, revenue was 1.31 billion yuan, down 2.0% year-on-year, while net profit was 170 million yuan, a slight increase of 0.2% year-on-year [1]. Product and Brand Strategy - The company continues to advance its multi-brand strategy, with the white liquor segment generating 2.47 billion yuan in revenue in 25H1, a 0.7% increase year-on-year [2]. - The main brand, Laobai Ganjiu, reported revenue of 1.28 billion yuan, up 2.0% year-on-year, while Wulingjiu saw a 7.0% increase to 530 million yuan [2]. - The company focuses on core products priced between 100-300 yuan, effectively countering the impact of weak high-end product sales [2]. Cost Management and Profitability - The gross margin for 25H1 was 68.0%, an increase of 2.1 percentage points year-on-year, attributed to effective cost control [3]. - The net profit margin improved to 12.9%, up 0.6 percentage points year-on-year, indicating enhanced profitability [3]. - However, cash flow from operations was under pressure, with a net cash flow of -50 million yuan, a decline of 120.5% year-on-year [3]. Internal Reforms and Future Outlook - The company is deepening internal reforms to enhance operational efficiency, including the transfer of equity from subsidiaries to the headquarters [4]. - The company is expected to see net profits of 810 million yuan, 890 million yuan, and 1.01 billion yuan for 2025-2027, with corresponding EPS of 0.88 yuan, 0.98 yuan, and 1.11 yuan [4]. - A target price of 22.88 yuan is set based on a 26x valuation for 2025, maintaining a "buy" rating [4].
贵州茅台注册《堆叠柱形图绘制软件V1.0.0》项目软件著作权
Zheng Quan Zhi Xing· 2025-09-04 00:29
【中国白酒网】近日贵州茅台(600519)新注册了《堆叠柱形图绘制软件V1.0.0》项目的软件著作 权。今年以来贵州茅台新注册软件著作权5个,较去年同期增加了400%。结合公司2025年中报财务数 据,今年上半年公司在研发方面投入了7390.15万元,同比减20.03%。 数据来源:天眼查APP 通过天眼查大数据分析,贵州茅台酒股份有限公司共对外投资了13家企业,参与招投标项目7609 次;财产线索方面有商标信息32条,专利信息622条,著作权信息68条;此外企业还拥有行政许可184 个。 ...
顺鑫农业白酒产业半年营收降逾23% 产能利用率不足28%急需提振
Chang Jiang Shang Bao· 2025-09-03 23:58
当前,顺鑫农业(000860)(000860.SZ)的发展并不"顺心"。 近日,顺鑫农业发布2025年半年报,公司上半年实现营业收入45.93亿元,同比下降19.24%;净利润 1.73亿元,同比下降59.09%。 其中,上半年,顺鑫农业白酒产业实现营业收入36.06亿元,同比减少23.25%。 半年报显示,截至2025年上半年底,顺鑫农业产能合计825500千升,上半年实际产能113822千升,公司 上半年产能利用率仅27.58%。 而且,2025年上半年,顺鑫农业北京地区营业收入达13.94亿元,同比下降12.97%;外埠地区营业收入 达31.99亿元,同比下降21.69%。 目前,顺鑫农业白酒业务正面临行业分化加剧、消费场景萎缩、新品市场开拓等风险。 上半年净利降59.09% 顺鑫农业是一家老牌国企,前身为牛栏山酒厂,1998年在深交所上市。目前,公司已形成了以白酒、猪 肉为主的两大产业。其中,顺鑫农业白酒产业的主要产品以"牛栏山"和"宁诚"为代表。 近日,顺鑫农业发布2025年半年报,公司上半年实现营业收入45.93亿元,同比下降19.24%;净利润 1.73亿元,同比下降59.09%。 对此,顺鑫农 ...
开源晨会0904-20250904
KAIYUAN SECURITIES· 2025-09-03 23:31
Group 1: Macro Economic Insights - The recent appreciation of the RMB against the USD may be seen as a "catch-up" due to a weaker dollar environment, with the RMB appreciating by approximately 2.3% compared to a 10% depreciation of the dollar index in the first eight months of 2025 [5][6][7] - The domestic equity market's recovery and dovish signals from the Federal Reserve are key triggers for the recent rise in the RMB exchange rate, despite weaker manufacturing PMI data [6][8] - The RMB is expected to continue appreciating, but short-term fluctuations may occur due to uncertainties in global economic policies, particularly in Japan [8][9] Group 2: ETF Market Dynamics - Since June, non-broad-based ETFs have seen rapid growth, with net inflows reaching 227.9 billion RMB, indicating a shift in retail investor preferences towards ETFs [11][12] - Broad-based ETFs have experienced significant net redemptions, suggesting that while overall ETF inflows may appear modest, retail funds are actively entering the market through non-broad-based ETFs [12][13] - The current bull market is characterized by a shift from actively managed funds to ETFs, driven by factors such as product variety, cost efficiency, and ease of access [13][14] Group 3: Power Equipment and New Energy Sector - The photovoltaic industry is facing severe overcapacity, with nominal production capacity exceeding 1200 GW, leading to significant price declines across the supply chain [18][19] - Recent government initiatives aim to curb internal competition and stabilize the market, with signs of price recovery in the polysilicon segment [19][20] - Despite ongoing losses in the main supply chain, specialized companies are performing better than integrated firms, indicating a potential for recovery as supply-demand dynamics improve [20][21] Group 4: Chemical Industry Performance - The chemical raw materials and products manufacturing sector reported a revenue of 4.46359 trillion RMB in H1 2025, a year-on-year increase of 1.4%, but profits fell by 9% to 181.46 billion RMB [23][24] - The basic chemical industry achieved a revenue of 1.1707 trillion RMB in H1 2025, with a profit of 73.17 billion RMB, reflecting a 3.5% revenue increase year-on-year [24][25] - The petrochemical sector, excluding major state-owned enterprises, saw a revenue decline of 7.3% in H1 2025, indicating challenges in profitability [25][26] Group 5: Pharmaceutical Sector Developments - Sunshine Nuohuo (688621.SH) reported a revenue of 590 million RMB in H1 2025, a 4.87% increase, with a significant Q2 performance showing a 15.73% year-on-year growth [28][29] - The company is advancing its innovative drug pipeline, with multiple projects in clinical trials, indicating a strong growth trajectory [29][30] - Haofan Bio (301393.SZ) achieved a revenue of 270 million RMB in H1 2025, reflecting a 20.10% increase, driven by strong demand for GLP-1 drugs [32][33] Group 6: Food and Beverage Sector Insights - Shanxi Fenjiu (600809.SH) reported a revenue of 23.96 billion RMB in H1 2025, a 5.4% increase, but faced pressure on profit margins due to changing consumer preferences [40][41] - Wuliangye (000858.SZ) achieved a revenue of 52.77 billion RMB in H1 2025, a 4.2% increase, but is navigating challenges in maintaining price stability amid competitive pressures [45][46]
山西杏花村汾酒厂股份有限公司关于董事会换届选举的公告
证券代码:600809 证券简称:山西汾酒 公告编号:临2025-023 公司于2025年9月3日召开第八届董事会第七十七次会议,审议通过了《关于董事会换届选举独立董事的 议案》《关于董事会换届选举非独立董事的议案》。 董事会同意提名袁清茂先生、武跃飞先生、李振寰先生、刘卫华先生、王彦先生、马文杰先生为公司第 九届董事会非独立董事候选人;提名周培玉先生、李临春先生、樊燕萍女士、贺祯先生为公司第九届董 事会独立董事候选人。任期自股东大会选举通过之日起三年。(上述候选人简历附后) 上述候选人的任职资格已经公司第八届董事会提名委员会审查通过。独立董事候选人周培玉先生、李临 春先生、樊燕萍女士、贺祯先生均已取得《独立董事资格证书》。独立董事候选人的任职资格和独立性 已经上海证券交易所备案审核无异议。 为确保董事会的正常运行,在新一届董事就任前,公司第八届董事会成员仍将继续依照法律法规和公司 《章程》等有关规定,忠实勤勉地履行董事职责。 特此公告 山西杏花村汾酒厂股份有限公司 关于董事会换届选举的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承 ...